Pancreatic cancer is one of the most painful cancers, but modern palliative care can control that pain for the vast majority of patients. Among all cancer types, pancreatic cancer has the highest rate of pain in the final week of life, affecting roughly 86% of patients. Severe pain occurs in about 39% of cases. Those numbers are real, but so is the other side: when patients receive appropriate end-of-life care, complete or partial pain relief is achieved in over 99% of cases across all cancer types.
If you’re searching this, you’re probably facing something terrifying with someone you love, or confronting your own diagnosis. Here’s what actually happens, what causes the pain, and what can be done about it.
Why Pancreatic Cancer Causes So Much Pain
The pancreas sits deep in the upper abdomen, surrounded by a dense web of nerves called the celiac plexus. This nerve cluster acts as a relay station, carrying pain signals from the abdominal organs to the brain. As a pancreatic tumor grows, it can invade nerve sheaths and neural clusters directly, essentially embedding itself in the body’s pain-signaling wiring. Few other cancers have this kind of direct access to such a concentrated nerve network.
The pain comes from multiple sources at once. The tumor can block the pancreatic duct, causing pressure to build inside the gland. It can compress or infiltrate surrounding nerves. It can trigger inflammation in the gland itself. This combination of duct obstruction, nerve invasion, and tissue inflammation produces pain that is visceral, somatic, and neuropathic all at the same time. That’s a clinical way of saying the pain can feel like deep abdominal aching, sharp localized soreness, and burning or shooting nerve pain, often radiating from the upper abdomen through to the back.
How Pain Is Managed at End of Life
Pain management for pancreatic cancer follows a stepwise approach. It typically starts with standard pain relievers, then moves to mild opioids, then to stronger opioids like morphine, which remains the first-line treatment for moderate to severe pancreatic cancer pain. Most patients take these medications by mouth in two forms: a long-acting version for steady baseline control and a rapid-onset version for sudden flares of pain (called breakthrough pain).
When swallowing becomes difficult, medication can be delivered through skin patches, under the tongue, as a nasal spray, or through a small needle just under the skin. Fentanyl patches, for instance, provide steady pain relief for patients whose opioid needs are stable, while fast-acting fentanyl formulations handle sudden spikes. For nerve-related pain specifically, medications originally designed for seizures can be added to reduce that burning, shooting quality and lower the overall amount of opioids needed.
One of the most effective tools specific to pancreatic cancer is a procedure called a celiac plexus block. This involves injecting a substance near that nerve cluster in the abdomen to interrupt pain signals at their source. The success rate is roughly 80%, and relief typically lasts several weeks to months. The procedure works best when performed early, before the tumor has spread extensively over the nerve cluster, because at that point the blocking agent can’t reach enough of the nerve tissue. Patients who receive this procedure report meaningful improvements in quality of life for at least five weeks afterward.
For patients in the final stage whose pain resists all of these approaches, implantable pumps can deliver tiny doses of pain medication directly into the spinal fluid. This method uses far less medication than oral or injectable routes, which means fewer side effects like drowsiness and nausea while still providing strong relief. Steroids may also be added to reduce swelling and pressure around the tumor.
When Pain Becomes Uncontrollable
In a small number of cases, pain or other distressing symptoms do not respond adequately to any combination of medications. When this happens, palliative sedation becomes an option. This involves using medication to lower consciousness enough that the patient is no longer aware of their suffering. It is reserved for patients whose death is expected soon and whose symptoms have genuinely resisted every other treatment at maximum doses.
Palliative sedation is not the same as hastening death. It is a recognized medical practice with clear guidelines, involving documented discussions with the patient or their family about goals of care. The most common reasons it’s used are uncontrollable delirium, intractable pain, and severe difficulty breathing. It exists specifically so that no one has to die in agony when all other options have been exhausted.
What the Final Days Look Like
In the last days and hours, the body goes through a series of changes that are largely predictable. Most patients with advanced cancer experience a progressive decline in awareness, with decreased consciousness present in about 97% of patients during their final three days. The median onset of noticeably reduced consciousness is about seven days before death. By two to three days before death, most patients show decreased response to voices and visual stimuli.
Breathing patterns change, sometimes becoming irregular or developing a cycle of deep breaths followed by pauses. A rattling sound from fluid in the throat is common in the final day or two. These signs can be distressing to witness, but by this point, the patient’s neurological function has declined significantly. The progressive loss of awareness means that most patients are not consciously experiencing pain or distress during these final hours, even if their body shows reflexive movements or sounds.
This is an important distinction for families keeping vigil. A patient may moan, grimace, or move restlessly in ways that look like suffering. Sometimes this is pain that needs to be treated, but often it is terminal agitation, a state of restlessness driven by the brain’s declining function rather than by physical pain. Terminal agitation can involve tossing and turning, pulling at sheets or clothing, mumbling, and facial expressions that mimic pain. Care teams are trained to distinguish between the two and adjust medications accordingly, but it helps families to know that what looks like suffering is not always what it appears.
The Honest Picture
Pancreatic cancer can cause severe pain, and it does so more often than most other cancers. That is the difficult truth. But the tools available to manage that pain are extensive and, in the hands of experienced palliative care teams, effective for the overwhelming majority of patients. A large national registry study found that only 0.2% of cancer patients at end of life received no relief from their pain at all.
The biggest factor in whether someone dies in pain is not the disease itself but whether they have access to good palliative care. Patients enrolled in hospice or palliative care programs early tend to have better pain control, because their care teams have time to find the right combination of medications, perform procedures like celiac plexus blocks before the window closes, and build a plan that adapts as the disease progresses. For stage IV pancreatic cancer, where median survival is around seven months, that window matters. Early palliative care involvement is not giving up. It is the single most effective thing that can be done to prevent a painful death.